An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan

NCT06156982 · clinicaltrials.gov ↗

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Evusheld

Sponsor

AstraZeneca